title: Influenza vaccination and hemostasis: no sustainable procoagulant effects from 2009 H1N1 influenza vaccine in healthy healthcare workers.
authors.forename: P M
authors.initials: PM
authors.lastname: Smit
authors.forename: S
authors.initials: S
authors.lastname: Veldhuis
authors.forename: J W
authors.initials: JW
authors.lastname: Mulder
authors.forename: C
authors.initials: C
authors.lastname: Roggeveen
authors.forename: G F
authors.initials: GF
authors.lastname: Rimmelzwaan
authors.forename: J C M
authors.initials: JC
authors.lastname: Meijers
authors.forename: J H
authors.initials: JH
authors.lastname: Beijnen
authors.forename: D P M
authors.initials: DP
authors.lastname: Brandjes
mesh_terms: D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D001780:Blood Coagulation Tests; D005260:Female; D006282:Health Personnel; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D007115:Immunization Schedule; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects; D007251:Influenza, Human / Q000276:immunology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D009426:Netherlands; D055815:Young Adult
chemical_list: D015415:Biomarkers; D007252:Influenza Vaccines; C558220:focetria